Stock Events

Stock Events

UroGen Pharma (0XOD.LSE) Q4 2023 Earnings

14MarConfirmed

Q4 2023

-0.72

-0.71

-0.69

-0.68

Details

Expected EPS

-0.68

Actual EPS

-0.72

Surprise EPS

-0.04

Surprise Percent

+5.88%

Description

UroGen Pharma (0XOD.LSE) has reported earnings of -0.72 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.